share_log

百花医药(600721.SH)发布前三季度业绩,净利润2395万元,同比增长35.39%

xinjiang bai hua cun pharma tech (600721.SH) released its performance for the first three quarters, with a net income of 23.95 million yuan, a year-on-year increase of 35.39%.

Zhitong Finance ·  Oct 24, 2024 15:47

Xinjiang Bai Hua Cun Pharma Tech (600721.SH) disclosed its third quarter report for 2024, achieving operating income of 2....

According to the Zhitong Finance app, Xinjiang Bai Hua Cun Pharma Tech (600721.SH) disclosed its third quarter report for 2024, with operating income of 0.291 billion yuan, a year-on-year increase of 9.38%; net income attributable to the parent company was 23.95 million yuan, a year-on-year increase of 35.39%; non-net profit was 21.7 million yuan, a year-on-year increase of 32.52%; and basic earnings per share were 0.0627 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment